Clinical trials
Terminated Carcinoma, Renal Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 6 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 3 |
| Agenus Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| AHS Cancer Control Alberta | 1 |
| Argos Therapeutics | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Incyte Corporation | 1 |
| MacroGenics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 20 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Melanoma | 6 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Transitional Cell | 3 |
| Kidney Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Urinary Bladder Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.